|
Name: Flurazepam
Type: Benzodiazepine
AKA: Dalmane
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Flurazepam, introduced in the 1970s, is a benzodiazepine used to treat insomnia and anxiety. It was one of the first long-acting benzodiazepines, offering prolonged sedation and sleep benefits, though its use has decreased with the introduction of newer medications.
|
|
V. Legal Information
Flurazepam, a benzodiazepine used for treating insomnia, is classified as a controlled substance due to its potential for abuse. In the US, it is listed under Schedule IV.
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Flurazepam is a benzodiazepine used for treating insomnia and anxiety. As a downer, it promotes relaxation and sleep. Short-term effects include improved sleep quality and reduced anxiety, while long-term use may lead to dependence and tolerance. Overdose risks involve excessive sedation and potential respiratory issues. Safe dosing is typically guided by a healthcare provider. Recent research highlights its effectiveness and potential risks of misuse.  |
|
VII. Psychological Effects
Flurazepam, a benzodiazepine, affects GABA-A receptors, providing sedation and anxiolysis. Immediate effects include reduced anxiety and improved mood, with effects lasting up to 24 hours. Long-term use can lead to cognitive decline, dependence, and mood disturbances. Research indicates risks of cognitive impairment and psychological dependence with prolonged use.
 |
|
VIII. Culture
Flurazepam is a benzodiazepine used for the treatment of insomnia, classifying it as a downer. Short-term use induces sedation and promotes sleep, while long-term use can lead to dependence, tolerance, and cognitive impairment. Overdose risks include severe sedation, respiratory depression, and potential for coma. Safe dosages are prescribed by medical professionals, typically not exceeding 30 mg per day. Recent research highlights its effectiveness in sleep disorders but warns of high dependence risks and cognitive effects. Physical effects include drowsiness, impaired coordination, and potential respiratory depression.
 |